openPR Logo
Press release

Anticonvulsants Drug Market Research Report by Key Players Analysis 2025

07-05-2017 01:39 PM CET | Health & Medicine

Press release from: Transparency Market Research

Anticonvulsants Drug Market

Anticonvulsants Drug Market

The first line of treatment in pain management usually involves the use of pharmaceuticals from various therapeutic classes such as antidepressants, opioids, NSAIDs, anticonvulsants, anesthetics, and other non-narcotic analgesics. Anticonvulsants, also known as antiepileptic drugs, were developed primarily for the treatment of epileptic seizures. However, leading anticonvulsant drugs such as Lyrica (pregabalin) and Neurontin (gabapentin) have also been approved for the management of various pain indications including fibromyalgia, migraine and neuropathic pain. These approvals are responsible for the increasing importance of anticonvulsants in the management of various pain indications. The overall market for anticonvulsants is highly genericized; however, the market for anticonvulsants for pain management application is dominated by Lyrica, the only branded pharmaceutical among the currently marketed drugs.

Of the major anticonvulsant drugs currently marketed, Lyrica (pregabalin), Neurontin (gabapentin), Topamax (topiramate), Depakote (divalproex), and Carbatrol/Tegretol (carbamazepine) are indicated for management of various types of pain. In 2012, Lyrica registered sales of US$ 5,111 Mn, of which 74% constituted revenue from its pain management indication. Since all the other molecules are generic and have negligible contribution in the pain management application, the market will be driven and dominated by the sales of existing blockbuster drug Lyrica, which constituted 73.4% share of the total market in 2011. The drug was initially set to lose its patent exclusivity in 2015, which would have negatively impacted the market rendering it completely generic. However, Pfizer has obtained market exclusivity for the drug and its use in pain management through to 2018, and is therefore expected to maintain its leadership position.

This report gives readers a comprehensive overview of the Anticonvulsants Drug Market: http://www.transparencymarketresearch.com/anticonvulsants-drug-market.html

Rising prevalence of epilepsy is the key driver of the anticonsultants drug market. Anticonvulsants drug is not only consumed in case of epileptic seizures, but also for pain management in migraine, and fibromyalgia. This boosts the anticonvulsants drug market. Availability of alternative options for pain management acts as a major restraint of the market. Other pain management methods include the use of medical devices such as analgesic pumps and minimally invasive procedures such as denervation or rhizotomy. Pain management implants and devices such as neuromodulators are gaining market acceptance among medical professionals, while acupuncture and acupressure are world-renowned pain relief techniques along with physiotherapy that people adopt. Other devices included in pain relief are transcutaneous electrical nerve stimulation (TENS) that delivers mild shocks to nerves in order to block pain messages to the brain. Hence, competition in the market from other improved pain management methods, devices, and other drugs can also hamper the anticonvulsants drug market. The anticonvulsants drug market has been segmented based on therapeutic class, disease indication, formulation, distribution channel, and region.

Get accurate market forecast and analysis on the Anticonvulsants Drug Market. Request a sample to stay abreast on the key trends impacting this market: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=22973

In terms of region, the anticonvulsants drug market has been classified into Asia Pacific, Europe, Middle East & Africa, North America, and Latin America. Key players in the anticonvulsant drug market are Abbott Laboratories, Teva Pharmaceutical Industries Ltd., Johnson & Johnson Services, Inc., Novartis AG, Pfizer, Inc., Valeant Pharmaceuticals International, Inc., Sanofi, UCB, Shire plc., and Astrazeneca plc.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact us:

Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Anticonvulsants Drug Market Research Report by Key Players Analysis 2025 here

News-ID: 608978 • Views: 186

More Releases from Transparency Market Research

Pad Printing Machine Market - Provides Veritable Information on Size, Growth Tre …
Pad Printing Machine Market: An Overview Need for an effective printing machine which can lay down simple one colored image or complex multicolor graphics to about every object helped in the introduction of pad printing machine. It is used to transfer a 2-D image via a silicon padon to a 3-D object on any type of surface like flat, spherical, irregular or cylindrical. Pad printing machine also prints photos or other
Varnished Cambric Tape Market - Company Strategy, Product Portfolio and Recent D …
Varnished cambric tape Market: An Overview The growth of renewable power generation will be an elementary factor to push the demand for the electrical wires and cables market across the globe, the countries are focusing more on power generation through renewable resources available in comparison with conventional (coal, thermal, etc.) power generation methodology, the transmission and distribution of electrical infrastructure is not only required to be completely developed in developed economies
Hip Flask Market | Reporting and Evaluation of Recent Industry Developments & Bu …
Hip Flask Market: An Overview Similar to the mobile, the hip flask started to appear in the form it was recognized today in the 18th century, the primarily hip flask was mainly used by the well-born people of high social class especially in the past. Initially, the hip flask was made of malleable metal alloy (Pewter), silver, gold, copper, and glass, but nowadays hip flask is also available in stainless steel
Cargo Pit Tape Market - Research Forecast, Revenue Opportunities And Sales Volum …
Cargo Pit Tape Market: An Overview The most important element in packaging is quality of adhesive to be used in packaged items to maintain the same quality throughout the supply chain till the time it reaches the destination safely. There are many types of packaging tapes available in the market with different applications. Polypropylene Tape: it’s economical, durable, and reliable and resistant to breaking or tearing during the shipping. Printed Fragile Tape: It

All 5 Releases


More Releases for Anticonvulsants

Generic and branded anticonvulsants are restraining the growth of novel therapie …
Anticonvulsants, also commonly known as antiepileptic drugs or antiseizure drugs are a diverse group of pharmacology agents used in the treatment of epileptic seizures. Epilepsy is a chronic disorder resulting in repeated and unprovoked seizures. Epileptic seizures are commonly referred as convulsions. Anticonvulsants are mainly used for treatment of epileptic seizures. Epileptic seizures are caused by disturbance in the electrical activity of the brain. In addition, anticonvulsants are also used
Epileptic Anticonvulsants Market Size, Growth, Trends and 2020 Forecast Report
According to the WHO, nearly 80% of epilepsy patients are found in developing regions. However, developed regions are dominant in the global epileptic anticonvulsants market. Currently, North America dominates the epileptic anticonvulsants market, followed by Europe. Highly developed healthcare infrastructure, high level of awareness, high healthcare spending on epilepsy and related treatments, along with availability of skilled professionals to treat epilepsy are driving the North America and Europe epileptic anticonvulsants
Anticonvulsants for Neuropathic Pain Market unprovoked by 2025
Global Anticonvulsants for Neuropathic Pain Market: Snapshot Neuropathic pain, which refers to kind of chronic pain resulting from an injury to or disease of the central or peripheral nervous system, remains a therapeutic challenge to clinicians as it does not respond well to conventional pain therapies. Although the clinical knowledge regarding the pathogenesis of the condition has significantly increased over the past few decades, the actual mode of action of most
Anticonvulsants for Neuropathic Pain Market Business Strategy & Forecast by 2025
Global Anticonvulsants for Neuropathic Pain Market: Snapshot Neuropathic pain, which refers to kind of chronic pain resulting from an injury to or disease of the central or peripheral nervous system, remains a therapeutic challenge to clinicians as it does not respond well to conventional pain therapies. Although the clinical knowledge regarding the pathogenesis of the condition has significantly increased over the past few decades, the actual mode of action of most
Anticonvulsants Drug Market - Significant Growth During 2025
The first line of treatment in pain management usually involves the use of pharmaceuticals from various therapeutic classes such as antidepressants, opioids, NSAIDs, anticonvulsants, anesthetics, and other non-narcotic analgesics. Anticonvulsants, also known as antiepileptic drugs, were developed primarily for the treatment of epileptic seizures. However, leading anticonvulsant drugs such as Lyrica (pregabalin) and Neurontin (gabapentin) have also been approved for the management of various pain indications including fibromyalgia, migraine and
Anticonvulsants Drug Market: Upcoming Demands and Growth Analysis
The first line of treatment in pain management usually involves the use of pharmaceuticals from various therapeutic classes such as antidepressants, opioids, NSAIDs, anticonvulsants, anesthetics, and other non-narcotic analgesics. Anticonvulsants, also known as antiepileptic drugs, were developed primarily for the treatment of epileptic seizures. However, leading anticonvulsant drugs such as Lyrica (pregabalin) and Neurontin (gabapentin) have also been approved for the management of various pain indications including fibromyalgia, migraine and